Chantix unsuitable for first-line smoking cessation use
Wednesday, November 2, 2011 - 17:00
in Health & Medicine
The poor safety profile of the smoking-cessation drug varenicline (Chantix) makes it unsuitable for first-line use, according to a study published in the Nov. 2 edition of the journal PLoS One, an online publication of the Public Library of Science.